ArticleJournal of translational medicine2026

MiPEP133 enhances anti-tumor immunity in nasopharyngeal carcinoma by activating CD8 + T cells.

Mingjing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.